News

Optimizing the ALS Patient's Diet

Proper diet and exercise are critical for maintaining a healthy body weight, metabolism, and nutrition. However, hypermetabolism and weight loss are common side effects amongst ALS patients. When designing meal plans for individuals...
Read More...

SITRIN NEUROCARE HOSTS PREMIERE PARTY FOR "ALS & HD: YOU'VE GOT A FRIEND IN ME"

On Friday May 3, Sitrin NeuroCare hit the red carpet for a star-studded event. The specialty program premiered ALS & HD: You’ve Got a Friend in Me, a new music video...
Read More...

Scientists Uncover ALS Genetic Cause Mystery

About 35% of ALS cases are associated with mutations in the gene C9orf72, making it the most common genetic cause of ALS.
Read More...

Proteins Show Promise as Treatment for Huntington’s Disease

A protein that can specifically bind to mutated forms of huntingtin and prevent its production may represent a new strategy to attack Huntington’s Disease.
Read More...

Investigational Therapy CuATSM May Slow ALS Progression

The investigational therapy, CuATSM, has been found to possibly slow ALS disease progression and improve respiratory and cognitive function of patients.
Read More...

Huntington's Disease Study Enters Phase III

After a successful trial, a Huntington's Disease study is entering its third phase. The phase III trial will investigate whether a new drug can slow or improve symptoms for people with...
Read More...

Graphene May be Used to Detect ALS

Graphene, a material made up of a thin sheet of carbon, may be used in the future to detect and measure biomarkers able to identify patients with amyotrophic lateral sclerosis (ALS).
Read More...

BIIB067: Potential Treatment for ALS

The neuroscience company, Biogen, has acquired the rights to develop and commercialize BIIB067, an investigational therapy, as a potential treatment for amyotrophic lateral sclerosis (ALS).
Read More...

MORE THAN 200 PEOPLE WILL BE ENROLLED IN ALS CLINICAL TRIAL

A randomized and placebo-controlled clinical trial will enroll 231 people with ALS in North America and Europe to determine efficacy and safety of arimoclomol, a new oral drug.
Read More...

Medication Approved for Parkinson's May Benefit ALS

A medication known as Requip has been approved to treat Parkinson’s disease, and studies have shown that it may also be beneficial for amyotrophic lateral sclerosis (ALS).
Read More...

1 2 3 4 5 6